Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Well...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(8)
•••
Comment by Lemoyneon Dec 10, 2020 7:29pm
209 Views
Post# 32085248

RE:RE:RE:RE:RE:RE:RE:RE:Well...

RE:RE:RE:RE:RE:RE:RE:RE:Well...Look, this is speculation, but IMO, I think they timed the CEO change because they know Q4 is decent, at least part of them, (ie white label growth) and they want to turn the page with new high management on the getgo for what would be a break out year in 2021. I doubt they would sack Pat to have the new CEO start off with bad news in Q4, it wouldn't make sense to have new CEO put on the chopping block right off the bat. If bad news were coming in Q4 they'd let Pat eat dirt and sack him afterwards, giving the first good news to new CEO.

I also doubt they'd be able to recruit high level CEO with a bad news start.

Whatever this opinion is worth, I've been wrong before.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities